======= PRMT1 ======= == Gene Information == * **Official Symbol**: PRMT1 * **Official Name**: protein arginine methyltransferase 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=3276|3276]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q99873|Q99873]] * **Interactions**: [[https://thebiogrid.org/search.php?search=PRMT1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PRMT1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/602950|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a member of the protein arginine N-methyltransferase (PRMT) family. Post-translational modification of target proteins by PRMTs plays an important regulatory role in many biological processes, whereby PRMTs methylate arginine residues by transferring methyl groups from S-adenosyl-L-methionine to terminal guanidino nitrogen atoms. The encoded protein is a type I PRMT and is responsible for the majority of cellular arginine methylation activity. Increased expression of this gene may play a role in many types of cancer. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene, and a pseudogene of this gene is located on the long arm of chromosome 5. [provided by RefSeq, Dec 2011]. * **UniProt Summary**: N/A |Methyltransf 11| |Methyltransf 18| |PrmA| |PRMT5| |N-methyltransferase activity| |positive regulation of hemoglobin biosynthetic process| |histone methyltransferase activity (H4-R3 specific)| |regulation of hemoglobin biosynthetic process| |protein-arginine omega-N monomethyltransferase activity| |negative regulation of megakaryocyte differentiation| |mitogen-activated protein kinase p38 binding| |histone H4-R3 methylation| |protein-arginine N-methyltransferase activity| |peptidyl-arginine methylation, to asymmetrical-dimethyl arginine| |protein-arginine omega-N asymmetric methyltransferase activity| |histone-arginine N-methyltransferase activity| |protein methyltransferase activity| |S-adenosyl-L-methionine binding| |peptidyl-arginine omega-N-methylation| |peptidyl-arginine N-methylation| |histone methyltransferase activity| |methylosome| |histone arginine methylation| |peptidyl-arginine methylation| |methyl-CpG binding| |peptidyl-arginine modification| |positive regulation of p38MAPK cascade| |positive regulation of erythrocyte differentiation| |regulation of p38MAPK cascade| |regulation of erythrocyte differentiation| |methyltransferase activity| |regulation of megakaryocyte differentiation| |DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest| |intracellular signal transduction involved in G1 DNA damage checkpoint| |signal transduction involved in mitotic DNA integrity checkpoint| |signal transduction involved in mitotic DNA damage checkpoint| |signal transduction involved in mitotic G1 DNA damage checkpoint| |signal transduction involved in mitotic cell cycle checkpoint| |mitotic G1 DNA damage checkpoint| |mitotic G1/S transition checkpoint| |G1 DNA damage checkpoint| |signal transduction involved in DNA damage checkpoint| |signal transduction involved in DNA integrity checkpoint| |signal transduction involved in cell cycle checkpoint| |negative regulation of myeloid cell differentiation| |DNA damage response, signal transduction by p53 class mediator| |positive regulation of cell cycle arrest| |positive regulation of myeloid cell differentiation| |histone methylation| |mitotic DNA damage checkpoint| |negative regulation of G1/S transition of mitotic cell cycle| |signal transduction in response to DNA damage| |mitotic DNA integrity checkpoint| |negative regulation of cell cycle G1/S phase transition| |regulation of cell cycle arrest| |signal transduction by p53 class mediator| |DNA damage checkpoint| |protein alkylation| |protein methylation| |negative regulation of hemopoiesis| |DNA integrity checkpoint| |regulation of G1/S transition of mitotic cell cycle| |mitotic cell cycle checkpoint| |regulation of cell cycle G1/S phase transition| |positive regulation of stress-activated MAPK cascade| |positive regulation of stress-activated protein kinase signaling cascade| |positive regulation of hemopoiesis| |cell cycle checkpoint| |negative regulation of mitotic cell cycle phase transition| |regulation of myeloid cell differentiation| |negative regulation of cell cycle phase transition| |regulation of stress-activated MAPK cascade| |regulation of stress-activated protein kinase signaling cascade| |macromolecule methylation| |positive regulation of cell cycle process| |negative regulation of mitotic cell cycle| |methylation| |negative regulation of cell cycle process| |protein homooligomerization| |enzyme binding| |histone modification| |covalent chromatin modification| |positive regulation of cell cycle| |in utero embryonic development| |regulation of mitotic cell cycle phase transition| |negative regulation of immune system process| |regulation of cell cycle phase transition| |regulation of hemopoiesis| |protein complex oligomerization| |positive regulation of MAPK cascade| |negative regulation of cell cycle| |mitotic cell cycle process| |regulation of mitotic cell cycle| |chordate embryonic development| |embryo development ending in birth or egg hatching| |neuron projection development| |mitotic cell cycle| |chromatin organization| |negative regulation of cell differentiation| |regulation of cellular response to stress| |regulation of cell cycle process| |regulation of MAPK cascade| |cellular response to DNA damage stimulus| |neuron development| |peptidyl-amino acid modification| |positive regulation of cell population proliferation| |negative regulation of developmental process| |positive regulation of cell differentiation| |embryo development| |cell cycle process| |neuron differentiation| |positive regulation of protein phosphorylation| |positive regulation of intracellular signal transduction| |positive regulation of phosphorylation| |chromosome organization| |identical protein binding| |plasma membrane bounded cell projection organization| |positive regulation of phosphorus metabolic process| |positive regulation of phosphate metabolic process| |positive regulation of immune system process| |cell projection organization| |regulation of cell cycle| |negative regulation of multicellular organismal process| |positive regulation of protein modification process| |cell cycle| |positive regulation of developmental process| |RNA binding| |regulation of protein phosphorylation| |regulation of response to stress| |generation of neurons| |protein-containing complex assembly| |regulation of phosphorylation| |positive regulation of cellular protein metabolic process| |regulation of cell population proliferation| |neurogenesis| |cell development| |regulation of immune system process| |positive regulation of signal transduction| |intracellular signal transduction| |cellular response to stress| |positive regulation of protein metabolic process| |positive regulation of multicellular organismal process| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |regulation of cell differentiation| |positive regulation of cell communication| |positive regulation of signaling| |regulation of intracellular signal transduction| |regulation of protein modification process| |protein-containing complex subunit organization| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp134|MS023 2μM R03 exp134]]|-2.65| |[[:results:exp459|Bleomycin 5μM R08 exp459]]|-2.34| |[[:results:exp505|ML-792 0.2μM R08 exp505]]|-1.98| |[[:results:exp84|UM0125461 0.74μM R02 exp84]]|-1.92| |[[:results:exp466|Cannabidiol 20μM R08 exp466]]|-1.91| |[[:results:exp241|QNZ 0.01μM R05 exp241]]|-1.83| |[[:results:exp41|BI-2536 0.001μM R01 exp41]]|-1.78| |[[:results:exp47|Lapatinib 5μM R01 exp47]]|-1.78| |[[:results:exp334|All-trans-Retinoic-Acid 40μM R07 exp334]]|-1.71| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 688/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|1/1| |bile duct|27/28| |blood|28/28| |bone|25/25| |breast|32/33| |central nervous system|55/56| |cervix|4/4| |colorectal|17/17| |esophagus|12/13| |fibroblast|1/1| |gastric|12/15| |kidney|20/21| |liver|20/20| |lung|67/75| |lymphocyte|14/14| |ovary|22/26| |pancreas|23/24| |peripheral nervous system|16/16| |plasma cell|13/15| |prostate|1/1| |skin|23/24| |soft tissue|7/7| |thyroid|2/2| |upper aerodigestive|20/22| |urinary tract|28/29| |uterus|5/5| == Essentiality in NALM6 == * **Essentiality Rank**: 418 * **Expression level (log2 read counts)**: 7.46 {{:chemogenomics:nalm6 dist.png?nolink |}}